Vireo Growth, Inc. engages in the business of operating cannabis cultivation, production, and dispensary facilities, and manufacturing cannabis products in environmentally friendly greenhouses. It operates through the following product segments: Inhalable, Ingestible, and Topicals. The Inhalable segment includes flower and trim, dabbable concentrates, distillate pre-filled vaporizer pens, cartridges, pre-rolls, and distillate syringes. The Ingestible segment focuses on edibles, tablets, softgels, oral solutions, oral spray, tinctures, and lozenges. The Topicals segment offers balms and topical bars. The company was founded by Kyle E. Kingsley on November 23, 2004 and is headquartered in Minneapolis, MN.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company